Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Register today
: Join us for the Fierce Health Payer Summit in November
AstraZeneca
Health Tech
Tempus AI aims to raise $400M in IPO
The Chicago-based company is looking to raise as much as $410.7 million by selling 11.1 million shares at a price range of $35 to $37 a share.
Heather Landi
Jun 7, 2024 7:00am
Pfizer taps Tempus' AI for cancer drug development
Mar 2, 2023 7:23am
Federal appeals court hands pharma a win on 340B restrictions
Jan 31, 2023 12:50pm
24 states support feds in 340B drugmaker lawsuit
May 17, 2022 7:50am
J&J to cut off 340B discounts to pharmacies starting in May
Mar 22, 2022 3:10pm
Judge sides with AstraZeneca in 340B contract pharmacy lawsuit
Feb 17, 2022 1:09pm
